You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 273 No. 2, January 11, 1995 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contributions
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Natural History of the Systemic Inflammatory Response Syndrome (SIRS)

A Prospective Study

M. Sigfrido Rangel-Frausto, MD, MSc; Didier Pittet, MD; Michele Costigan, RN, BSN; Taekyu Hwang, MS; Charles S. Davis, PhD; Richard P. Wenzel, MD, MSc

JAMA. 1995;273(2):117-123.


Abstract

Objective.
—Define the epidemiology of the four recently classified syndromes describing the biologic response to infection: systemic inflammatory response syndrome (SIRS), sepsis, severe sepsis, and septic shock.

Design.
—Prospective cohort study with a follow-up of 28 days or until discharge if earlier.

Setting.
—Three intensive care units and three general wards in a tertiary health care institution.

Methods.
—Patients were included if they met at least two of the criteria for SIRS: fever or hypothermia, tachycardia, tachypnea, or abnormal white blood cell count.

Main Outcomes Measures.
—Development of any stage of the biologic response to infection: sepsis, severe sepsis, septic shock, end-organ dysfunction, and death.

Results.
—During the study period 3708 patients were admitted to the survey units, and 2527 (68%) met the criteria for SIRS. The incidence density rates for SIRS in the surgical, medical, and cardiovascular intensive care units were 857,804, and 542 episodes per 1000 patient-days, respectively, and 671,495, and 320 per 1000 patient-days for the medical, cardiothoracic, and general surgery wards, respectively. Among patients with SIRS, 649 (26%) developed sepsis, 467 (18%) developed severe sepsis, and 110 (4%) developed septic shock. The median interval from SIRS to sepsis was inversely correlated with the number of SIRS criteria (two, three, or all four) that the patients met. As the population of patients progressed from SIRS to septic shock, increasing proportions had adult respiratory distress syndrome, disseminated intravascular coagulation, acute renal failure, and shock. Positive blood cultures were found in 17% of patients with sepsis, in 25% with severe sepsis, and in 69% with septic shock. There were also stepwise increases in mortality rates in the hierarchy from SIRS, sepsis, severe sepsis, and septic shock: 7%, 16%, 20%, and 46%, respectively. Of interest, we also observed equal numbers of patients who appeared to have sepsis, severe sepsis, and septic shock but who had negative cultures. They had been prescribed empirical antibiotics for a median of 3 days. The cause of the systemic inflammatory response in these culture-negative populations is unknown, but they had similar morbidity and mortality rates as the respective culture-positive populations.

Conclusions.
—This prospective epidemiologic study of SIRS and related conditions provides, to our knowledge, the first evidence of a clinical progression from SIRS to sepsis to severe sepsis and septic shock.

(JAMA. 1995;273:117-123)



Author Affiliations

From the Division of General Medicine, Clinical Epidemiology, and Health Services Research, Department of Internal Medicine (Drs Rangel-Frausto and Wenzel and Ms Costigan), and Division of Biostatistics, Department of Preventive Medicine (Dr Davis and Mr Hwang), University of Iowa College of Medicine, Iowa City; and Infection Control Group, Division of Infectious Diseases, Department of Internal Medicine, University Hospital, Geneva, Switzerland (Dr Pittet). Dr Wenzel has served as a consultant for Pfizer Roerig, New York, NY.


Footnotes

Reprint requests to Division of General Medicine, C-41 GH, University of Iowa Hospitals and Clinics, Iowa City, IA 52242 (Dr Wenzel).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A systematic review of antibiotic dosing regimens for septic patients receiving continuous renal replacement therapy: do current studies supply sufficient data?
Li et al.
J Antimicrob Chemother 2009;64:929-937.
ABSTRACT | FULL TEXT  

A Novel Biomarker-guided Immunomodulatory Approach for the Therapy of Sepsis
Trapnell
Am. J. Respir. Crit. Care Med. 2009;180:585-586.
FULL TEXT  

Rapid and segmental specific dysregulation of AQP2, S256-pAQP2 and renal sodium transporters in rats with LPS-induced endotoxaemia
Olesen et al.
Nephrol Dial Transplant 2009;24:2338-2349.
ABSTRACT | FULL TEXT  

Severity assessment in community-acquired pneumonia: a review
Singanayagam et al.
QJM 2009;102:379-388.
ABSTRACT | FULL TEXT  

Silencing of Fas-associated Death Domain Protects Mice from Septic Lung Inflammation and Apoptosis
Matsuda et al.
Am. J. Respir. Crit. Care Med. 2009;179:806-815.
ABSTRACT | FULL TEXT  

Distinct Functions of Activated Protein C Differentially Attenuate Acute Kidney Injury
Gupta et al.
J. Am. Soc. Nephrol. 2009;20:267-277.
ABSTRACT | FULL TEXT  

Acute Kidney Injury: New Concepts in Definition, Diagnosis, Pathophysiology, and Treatment
Lattanzio and Kopyt
JAOA: Journal of the American Osteopathic Association 2009;109:13-19.
ABSTRACT | FULL TEXT  

Diagnostic Efficacy and Prognostic Value of Serum Procalcitonin Concentration in Patients With Suspected Sepsis
Ruiz-Alvarez et al.
J Intensive Care Med 2009;24:63-71.
ABSTRACT  

Invited review: Deterioration of the immune system after trauma: signals and cellular mechanisms
Flohe et al.
Innate Immunity 2008;14:333-344.
ABSTRACT  

Bacterial DNA and its consequences in patients with cirrhosis and culture-negative, non-neutrocytic ascites
El-Naggar et al.
J Med Microbiol 2008;57:1533-1538.
ABSTRACT | FULL TEXT  

Methyl-2-acetamidoacrylate, an ethyl pyruvate analog, decreases sepsis-induced acute kidney injury in mice
Leelahavanichkul et al.
Am. J. Physiol. Renal Physiol. 2008;295:F1825-F1835.
ABSTRACT | FULL TEXT  

Roles of Heat Shock Proteins and {gamma}{delta}T Cells in Inflammation
Hirsh and Junger
Am. J. Respir. Cell Mol. Bio. 2008;39:509-513.
ABSTRACT | FULL TEXT  

How do we solve the puzzle of unintended consequences of inflammation? Systematically
Miles
J. Appl. Physiol. 2008;105:1023-1025.
FULL TEXT  

Diagnosis, Epidemiology and Outcomes of Acute Kidney Injury
Waikar et al.
CJASN 2008;3:844-861.
ABSTRACT | FULL TEXT  

Statins for infection and sepsis: a systematic review of the clinical evidence
Falagas et al.
J Antimicrob Chemother 2008;61:774-785.
ABSTRACT | FULL TEXT  

Bacterial DNA induces myocardial inflammation and reduces cardiomyocyte contractility: role of Toll-like receptor 9
Knuefermann et al.
Cardiovasc Res 2008;78:26-35.
ABSTRACT | FULL TEXT  

Sepsis: rethinking the approach to clinical research
Marshall
J. Leukoc. Biol. 2008;83:471-482.
ABSTRACT | FULL TEXT  

Hospital and 1-Year Outcomes of Septic Syndromes in Older People: A Cohort Study
Regazzoni et al.
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2008;63:210-212.
ABSTRACT | FULL TEXT  

Heat Shock Protein 90 Inhibitors Prolong Survival, Attenuate Inflammation, and Reduce Lung Injury in Murine Sepsis
Chatterjee et al.
Am. J. Respir. Crit. Care Med. 2007;176:667-675.
ABSTRACT | FULL TEXT  

Prostacyclin in endotoxemia-induced acute kidney injury: cyclooxygenase inhibition and renal prostacyclin synthase transgenic mice
Wang et al.
Am. J. Physiol. Renal Physiol. 2007;293:F1131-F1136.
ABSTRACT | FULL TEXT  

Silencing of caspase-8 and caspase-3 by RNA interference prevents vascular endothelial cell injury in mice with endotoxic shock
Matsuda et al.
Cardiovasc Res 2007;76:132-140.
ABSTRACT | FULL TEXT  

Erythropoietin ameliorates renal dysfunction during endotoxaemia
Mitra et al.
Nephrol Dial Transplant 2007;22:2349-2353.
ABSTRACT | FULL TEXT  

Activated protein C ameliorates LPS-induced acute kidney injury and downregulates renal INOS and angiotensin 2
Gupta et al.
Am. J. Physiol. Renal Physiol. 2007;293:F245-F254.
ABSTRACT | FULL TEXT  

Septic Acute Kidney Injury in Critically Ill Patients: Clinical Characteristics and Outcomes
Bagshaw et al.
CJASN 2007;2:431-439.
ABSTRACT | FULL TEXT  

Cytokine-mediated regulation of urea transporters during experimental endotoxemia
Schmidt et al.
Am. J. Physiol. Renal Physiol. 2007;292:F1479-F1489.
ABSTRACT | FULL TEXT  

A Prospective Comparison of New Japanese Criteria for Disseminated Intravascular Coagulation: New Japanese Criteria Versus ISTH Criteria
Hayakawa et al.
CLIN APPL THROMB HEMOST 2007;13:172-181.
ABSTRACT  

Regulation of Renal Sodium Transporters during Severe Inflammation
Schmidt et al.
J. Am. Soc. Nephrol. 2007;18:1072-1083.
ABSTRACT | FULL TEXT  

Role of Protein C in Renal Dysfunction after Polymicrobial Sepsis
Gupta et al.
J. Am. Soc. Nephrol. 2007;18:860-867.
ABSTRACT | FULL TEXT  

The CURB65 pneumonia severity score outperforms generic sepsis and early warning scores in predicting mortality in community-acquired pneumonia
Barlow et al.
Thorax 2007;62:253-259.
ABSTRACT | FULL TEXT  

Regulation of renal glucose transporters during severe inflammation
Schmidt et al.
Am. J. Physiol. Renal Physiol. 2007;292:F804-F811.
ABSTRACT | FULL TEXT  

A Prospective Comparative Study of Three Sets of Criteria for Disseminated Intravascular Coagulation: ISTH Criteria vs Japanese Criteria
Hayakawa et al.
CLIN APPL THROMB HEMOST 2007;13:65-72.
ABSTRACT  

Posterior Reversible Encephalopathy Syndrome in Infection, Sepsis, and Shock
Bartynski et al.
Am. J. Neuroradiol. 2006;27:2179-2190.
ABSTRACT | FULL TEXT  

Procalcitonin for early prediction of survival outcome in postoperative critically ill patients with severe sepsis
Dahaba et al.
Br J Anaesth 2006;97:503-508.
ABSTRACT | FULL TEXT  

Glutamine-Mediated Attenuation of Cellular Metabolic Dysfunction and Cell Death After Injury Is Dependent on Heat Shock Factor-1 Expression
Peng et al.
JPEN J Parenter Enteral Nutr 2006;30:373-379.
ABSTRACT | FULL TEXT  

Glutamine Attenuation of Cell Death and Inducible Nitric Oxide Synthase Expression Following Inflammatory Cytokine-Induced Injury Is Dependent on Heat Shock Factor-1 Expression
Peng et al.
JPEN J Parenter Enteral Nutr 2006;30:400-407.
ABSTRACT | FULL TEXT  

Agonistic Monoclonal Antibody Against CD40 Receptor Decreases Lymphocyte Apoptosis and Improves Survival in Sepsis
Schwulst et al.
J. Immunol. 2006;177:557-565.
ABSTRACT | FULL TEXT  

Upregulation of Renal Inducible Nitric Oxide Synthase during Human Endotoxemia and Sepsis Is Associated with Proximal Tubule Injury
Heemskerk et al.
CJASN 2006;1:853-862.
ABSTRACT | FULL TEXT  

Severe sepsis in community-acquired pneumonia: when does it happen, and do systemic inflammatory response syndrome criteria help predict course?
Dremsizov et al.
Chest 2006;129:968-978.
ABSTRACT | FULL TEXT  

Risk stratification of severe sepsis patients in the emergency department.
Chen et al.
Emerg. Med. J. 2006;23:281-285.
ABSTRACT | FULL TEXT  

Procalcitonin does discriminate between sepsis and systemic inflammatory response syndrome
Arkader et al.
Arch. Dis. Child. 2006;91:117-120.
ABSTRACT | FULL TEXT  

Multidrug-Resistant Pseudomonas aeruginosa: Risk Factors and Clinical Impact
Aloush et al.
Antimicrob. Agents Chemother. 2006;50:43-48.
ABSTRACT | FULL TEXT  

Early and innovative interventions for severe sepsis and septic shock: taking advantage of a window of opportunity
Rivers et al.
CMAJ 2005;173:1054-1065.
ABSTRACT | FULL TEXT  

Current Concepts in Severe Sepsis and Septic Shock
Rudis and Rowland
Journal of Pharmacy Practice 2005;18:351-362.
ABSTRACT  

Renal Failure Secondary to Acute Tubular Necrosis: Epidemiology, Diagnosis, and Management
Gill et al.
Chest 2005;128:2847-2863.
ABSTRACT | FULL TEXT  

Disseminated Intravascular Coagulation in Sepsis
Zeerleder et al.
Chest 2005;128:2864-2875.
ABSTRACT | FULL TEXT  

Procalcitonin, interleukin 6 and systemic inflammatory response syndrome (SIRS): early markers of postoperative sepsis after major surgery
Mokart et al.
Br J Anaesth 2005;94:767-773.
ABSTRACT | FULL TEXT  

Mechanism of Acute Fetal Cardiovascular Depression after Maternal Inflammatory Challenge in Mouse
Rounioja et al.
Am. J. Pathol. 2005;166:1585-1592.
ABSTRACT | FULL TEXT  

Endotoxemic acute renal failure is attenuated in caspase-1-deficient mice
Wang et al.
Am. J. Physiol. Renal Physiol. 2005;288:F997-F1004.
ABSTRACT | FULL TEXT  

Tumor necrosis factor-{alpha}-dependent expression of phosphodiesterase 2: role in endothelial hyperpermeability
Seybold et al.
Blood 2005;105:3569-3576.
ABSTRACT | FULL TEXT  

Incidence and Impact of Organ Dysfunctions Associated With Sepsis
Guidet et al.
Chest 2005;127:942-951.
ABSTRACT | FULL TEXT  

Should We Use Etomidate as an Induction Agent for Endotracheal Intubation in Patients With Septic Shock?: A Critical Appraisal
Jackson
Chest 2005;127:1031-1038.
ABSTRACT | FULL TEXT  

Systemic Inflammatory Response and Progression to Severe Sepsis in Critically Ill Infected Patients
Alberti et al.
Am. J. Respir. Crit. Care Med. 2005;171:461-468.
ABSTRACT | FULL TEXT  

Clarithromycin-Nifedipine Interaction as Possible Cause of Vasodilatory Shock
Geronimo-Pardo et al.
The Annals of Pharmacotherapy 2005;39:538-542.
ABSTRACT | FULL TEXT  

Cumulative Influence of Organ Dysfunctions and Septic State on Mortality of Critically Ill Children
Leclerc et al.
Am. J. Respir. Crit. Care Med. 2005;171:348-353.
ABSTRACT | FULL TEXT  

Shock on Admission Day Is the Best Predictor of Prolonged Mechanical Ventilation in the ICU
Estenssoro et al.
Chest 2005;127:598-603.
ABSTRACT | FULL TEXT  

Changes in the Novel Orphan, C5a Receptor (C5L2), during Experimental Sepsis and Sepsis in Humans
Huber-Lang et al.
J. Immunol. 2005;174:1104-1110.
ABSTRACT | FULL TEXT  

Evaluation of New Japanese Diagnostic Criteria for Disseminated Intravascular Coagulation in Critically Ill Patients
Gando et al.
CLIN APPL THROMB HEMOST 2005;11:71-76.
ABSTRACT  

Sepsis and the Role of Activated Protein C
Tazbir
Crit Care Nurse 2004;24:40-45.
FULL TEXT  

Bacterial Lipoprotein Delays Apoptosis in Human Neutrophils through Inhibition of Caspase-3 Activity: Regulatory Roles for CD14 and TLR-2
Power et al.
J. Immunol. 2004;173:5229-5237.
ABSTRACT | FULL TEXT  

Presence of Protein Fragments in Urine of Critically Ill Patients with Acute Renal Failure: A Nephrologic Enigma
Gai et al.
Clin. Chem. 2004;50:1822-1824.
FULL TEXT  

Soluble Form of the Triggering Receptor Expressed on Myeloid Cells-1 as a Marker of Microbial Infection
Gibot and Cravoisy
Clin Med Res 2004;2:181-187.
ABSTRACT | FULL TEXT  

Acute Renal Failure and Sepsis
Schrier and Wang
NEJM 2004;351:159-169.
FULL TEXT  

Plasma Level of a Triggering Receptor Expressed on Myeloid Cells-1: Its Diagnostic Accuracy in Patients with Suspected Sepsis
Gibot et al.
ANN INTERN MED 2004;141:9-15.
ABSTRACT | FULL TEXT  

Serum Levels of the Apoptosis-Associated Molecules, Tumor Necrosis Factor-{alpha}/Tumor Necrosis Factor Type-I Receptor and Fas/FasL, in Sepsis
De Freitas et al.
Chest 2004;125:2238-2246.
ABSTRACT | FULL TEXT  

Increased iNOS activity is essential for pulmonary epithelial tight junction dysfunction in endotoxemic mice
Han et al.
Am. J. Physiol. Lung Cell. Mol. Physiol. 2004;286:L259-L267.
ABSTRACT | FULL TEXT  

Aberrant Inflammation and Lethality to Septic Peritonitis in Mice Lacking STAT3 in Macrophages and Neutrophils
Matsukawa et al.
J. Immunol. 2003;171:6198-6205.
ABSTRACT | FULL TEXT  

The Effects of Vasopressin on Systemic and Splanchnic Hemodynamics and Metabolism in Endotoxin Shock
Martikainen et al.
Anesth. Analg. 2003;97:1756-1763.
ABSTRACT | FULL TEXT  

Intra-amniotic lipopolysaccharide leads to fetal cardiac dysfunction: A mouse model for fetal inflammatory response
Rounioja et al.
Cardiovasc Res 2003;60:156-164.
ABSTRACT | FULL TEXT  

Endotoxemia and Gram-negative bacteremia as predictors of outcome in sepsis: a meta-analysis using ROC curves
Hurley
Innate Immunity 2003;9:271-279.
ABSTRACT  

Statins, Inflammation, and Sepsis: Hypothesis
Almog
Chest 2003;124:740-743.
ABSTRACT | FULL TEXT  

Administration of C1 Inhibitor Reduces Neutrophil Activation in Patients with Sepsis
Zeerleder et al.
CVI 2003;10:529-535.
ABSTRACT | FULL TEXT  

Influence of Systemic Inflammatory Response Syndrome and Sepsis on Outcome of Critically Ill Infected Patients
Alberti et al.
Am. J. Respir. Crit. Care Med. 2003;168:77-84.
ABSTRACT | FULL TEXT  

Characterization of a Single Nucleotide Polymorphism in the Lipopolysaccharide Binding Protein and Its Association with Sepsis
Barber and O'Keefe
Am. J. Respir. Crit. Care Med. 2003;167:1316-1320.
ABSTRACT | FULL TEXT  

The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome
Aird
Blood 2003;101:3765-3777.
ABSTRACT | FULL TEXT  

The Epidemiology of Sepsis in the United States from 1979 through 2000
Martin et al.
NEJM 2003;348:1546-1554.
ABSTRACT | FULL TEXT  

Endogenous versus exogenous glucocorticoid responses to experimental bacterial sepsis
Silverstein and Johnson
J. Leukoc. Biol. 2003;73:417-427.
ABSTRACT | FULL TEXT  

Advances in the Understanding of Clinical Manifestations and Therapy of Severe Sepsis: An Update for Critical Care Nurses
Ely et al.
Am J Crit Care 2003;12:120-133.
ABSTRACT | FULL TEXT  

Respiratory Failure and Sepsis Are the Major Causes of ICU Admissions and Mortality in Survivors of Lung Transplants
Pietrantoni et al.
Chest 2003;123:504-509.
ABSTRACT | FULL TEXT  

Association of IL-10 polymorphism with severity of illness in community acquired pneumonia
Gallagher et al.
Thorax 2003;58:154-156.
ABSTRACT | FULL TEXT  

Epidemiology and Prognostic Determinants of Bloodstream Infections in Surgical Intensive Care
Harbarth et al.
Arch Surg 2002;137:1353-1359.
ABSTRACT | FULL TEXT  

Cyclooxygenase-2 Inhibition Attenuates Lipopolysaccharide-Induced Cardiovascular Failure
Hocherl et al.
Hypertension 2002;40:947-953.
ABSTRACT | FULL TEXT  

Granulocyte Macrophage-Colony Stimulating Factor Augmentation Therapy in Sepsis: Is There a Role?
Trapnell
Am. J. Respir. Crit. Care Med. 2002;166:129-130.
FULL TEXT  

Assessing Outcomes in Critical Care
Watson and Angus
J Intensive Care Med 2002;17:103-111.
ABSTRACT  

Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock
Rivers et al.
NEJM 2001;345:1368-1377.
ABSTRACT | FULL TEXT  

Treatment of sepsis with activated protein C
Hinds
BMJ 2001;323:881-882.
FULL TEXT  

Systemic Inflammatory Response Syndrome, Organ Failure, and Outcome in Critically Ill Obstetric Patients Treated in an ICU
Afessa et al.
Chest 2001;120:1271-1277.
ABSTRACT | FULL TEXT  

Mitochondrial Membrane Potential and Apoptosis Peripheral Blood Monocytes in Severe Human Sepsis
ADRIE et al.
Am. J. Respir. Crit. Care Med. 2001;164:389-395.
ABSTRACT | FULL TEXT  

Diagnostic Value of Procalcitonin, Interleukin-6, and Interleukin-8 in Critically Ill Patients Admitted with Suspected Sepsis
HARBARTH et al.
Am. J. Respir. Crit. Care Med. 2001;164:396-402.
ABSTRACT | FULL TEXT  

Editorial II: A momentary pause...
Gropper
Br J Anaesth 2001;86:746-749.
FULL TEXT  

The systemic inflammatory response syndrome
Meeran and Messent
Trauma 2001;3:89-100.
ABSTRACT  

Apoptosis in sepsis: a new target for therapeutic exploration
OBERHOLZER et al.
FASEB J. 2001;15:879-892.
ABSTRACT | FULL TEXT  

Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
Bernard et al.
NEJM 2001;344:699-709.
ABSTRACT | FULL TEXT  

Severe Sepsis -- A New Treatment with Both Anticoagulant and Antiinflammatory Properties
Matthay
NEJM 2001;344:759-762.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.